INS and metabolic dysfunction-associated steatotic liver disease: For example, pioglitazone and metformin, common treatments for glucose intolerance, can enhance insulin sensitivity in patients with NAFLD/NASH; however, other histological features, such as fibrosis, are not significantly influenced [105,106].